Wealthfront’s St Jude Medical STJ Stock Holding History

Wealthfront’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-5,728	Closed	-$459K	–	437
2016 Q4	$459K	Buy	5,728 +1,189	+26%	+$94.4K	0.01%	211
2016 Q3	$362K	Buy	4,539 +876	+24%	+$70.7K	0.01%	245
2016 Q2	$286K	Buy	+3,663	New	+$261K	0.01%	270
2015 Q4	–	Sell	-1,976	Closed	-$125K	–	1303
2015 Q3	$125K	Sell	1,976 -324	-14%	-$23.1K	0.01%	364
2015 Q2	$168K	Buy	2,300 +1,127	+96%	+$81.4K	0.01%	294
2015 Q1	$77K	Buy	1,173 +135	+13%	+$8.98K	﹤0.01%	433
2014 Q4	$68K	Buy	1,038 +536	+107%	+$34.5K	﹤0.01%	426
2014 Q3	$30K	Sell	502 -611	-55%	-$39.9K	﹤0.01%	483
2014 Q2	$78K	Buy	1,113 +422	+61%	+$27.4K	0.01%	276
2014 Q1	$46K	Buy	+691	New	+$45K	0.01%	286

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Wealthfront's STJ Position: Q1 2017 in Review

Wealthfront sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 5,728 shares — an estimated $459K sold.

Wealthfront first reported a position in STJ in Q1 2014 and held it in 10 quarters. The position peaked at $459K in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

Wealthfront reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
Wealthfront sold 5,728 St Jude Medical shares in Q1 2017, an estimated $459K.
Wealthfront first reported a position in St Jude Medical in Q1 2014 and held it in 10 quarters.
Wealthfront's St Jude Medical position peaked at $459K in Q4 2016.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Wealthfront's 13F filing for Q1 2017, filed 15 May 2017.